• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
Nairametrics
No Result
View All Result
Home Economy Socio Economic

WHO welcomes news of Merck’s antiviral Covid pill, awaits data ahead of approval

Chidinma Anyalewechi by Chidinma Anyalewechi
October 6, 2021
in Socio Economic
WHO welcomes news of Merck’s antiviral Covid pill, awaits data ahead of approval
Share on FacebookShare on TwitterShare on Linkedin

The World Health Organisation has welcomed Merck’s announcement of its Covid-19 antiviral pill. On Tuesday, the health organization said that Merck’s announcement of the effectiveness of its experimental antiviral pill against the most severe outcomes of Covid-19 is certainly good news.

Merck, the U.S. drugmaker announced on Friday that the antiviral pill named “Molnupiravir” has been proven to reduce the risk of hospitalization or death by around 50% for adults with mild to moderate cases of Covid.

In the phase three trial, it was discovered that the pill works by inhibiting the replication of the virus inside the body.

RelatedStories

WHO nominates Prof. Mohamed Janabi as regional director for Africa 

WHO nominates Prof. Mohamed Janabi as regional director for Africa 

May 19, 2025
mpox

Africa requires over $220 million to sustain Mpox response – Africa CDC, WHO 

April 17, 2025

Why this matters

The international agency has said it awaits clinical trial data on the drug. The WHO’s technical lead for Covid, Maria Van Kerkhove said, “We’re looking forward to receiving the data from them. I think everybody wants earlier treatment so that we prevent people from actually, you know, getting to that severe state and actually dying from the disease.”

Once the clinical trial data is available, the consideration to approved treatment will commence by the FDA. If the antiviral pill is given the green light and is approved by the Food and Drug Administration, it would potentially be the first pill to treat Covid.

A potentially game-changing advancement in the fight against the virus, which is killing an average of more than 1,700 Americans per day.

According to health experts, while vaccinations remain the best form of protection against the virus, a pill like Merck’s could keep the disease from progressing in those who do get infected and prevent trips to the hospital.

What they are saying

Dr. Mike Ryan, Executive Director of WHO’s Health Emergencies Program said that pills like Merck’s are considered a sort of “holy grail” for treatments, stating that the agency is still awaiting the raw clinical trial data on the drug.

Meanwhile, other drugmakers are also working on antiviral pills. In April, the CEO of Pfizer, Albert Bourla, said that the company is working on developing a pill like Merck’s, stating that it could be available by the end of this year.

The CEO also said that world leaders and public health officials should consider the cost of the drug on patients. He said, “The cost of treating millions of people early could have a significant cost, and maybe worth that investment but we have to look at how that’s going to work”.

Tags: Dr. Mike RyanWHOWorld Health Organisation
Chidinma Anyalewechi

Chidinma Anyalewechi

For further inquiries about this article, contact: Email: chidinma.anyalewechi@nairametrics.com LinkedIn: linkedin.com/in/chidinma-anyalewechi-a323ab173/

Related Posts

WHO nominates Prof. Mohamed Janabi as regional director for Africa 
Health

WHO nominates Prof. Mohamed Janabi as regional director for Africa 

May 19, 2025
mpox
Health

Africa requires over $220 million to sustain Mpox response – Africa CDC, WHO 

April 17, 2025
USAID places all staff globally on administrative leave from February 7, 2025 
Health

USAID withdrawal will disrupt essential services in northeast Nigeria – Stakeholders warn 

March 30, 2025
PenCom seeks bonds to clear N400 billion arrears as retirees groan
Health

Nigeria’s life expectancy at 54 years, below global average – Report

March 11, 2025
WHO, ITU launch global safe listening standard to prevent hearing loss among gamers 
Sectors

WHO, ITU launch global safe listening standard to prevent hearing loss among gamers 

March 3, 2025
Africa CDC says vaccine manufacturers in Africa to get approval for 8 vaccines by 2030 
Health

Africa CDC says vaccine manufacturers in Africa to get approval for 8 vaccines by 2030 

February 26, 2025
Next Post

Presco Plc announces board meeting, closed period ahead of Q3 2021 results.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Emple
nlng
first bank
Zenth Bank








DUNS

Recent News

  • WAES: West Africa exported goods valued at over $166 billion in 2024 – Tuggar 
  • Heineken withdraws staff, suspends operations in Eastern DRC cities amid worsening rebel conflict 
  • Tariff relief triggers $2 billion investment in Nigeria’s digital infrastructure – Tayo Aduloju

Follow us on social media:

Recent News

Yusuf Tuggar, Nigerian military

WAES: West Africa exported goods valued at over $166 billion in 2024 – Tuggar 

June 21, 2025
Heineken launches mandatory takeover bid of Champions Breweries, offers to buyout remaining 15.3% equity stake

Heineken withdraws staff, suspends operations in Eastern DRC cities amid worsening rebel conflict 

June 21, 2025
  • iOS App
  • Android App
  • Contact Us
  • Home
  • Markets
  • Sectors
  • Economy
  • Business News
  • Financial Literacy
  • Disclaimer
  • Ads Disclaimer
  • Copyright Infringement

© 2025 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Login
  • Sign Up

© 2025 Nairametrics